Acumen Pharmaceuticals, Inc. | TalkMarkets

Article By: Rod Raynovich

Monday, November 20, 2023 4:21 PM EDT

ETFs have not helped as portfolio fillers but they can identify trends. We should play this rally out of a biotech bear market.

In this article: IBB, XBI Also: GERN, EVH, CRSP, VCYT, TXG, ABOS

Article By: Rod Raynovich

Monday, July 17, 2023 1:47 PM EDT

Last week saw a broadening of the rally as many top sectors were up over 3%. But healthcare was among the laggards up only 0.7%.

In this article: UNH, IHI Also: PRHSX, IBB, XBI, XLV, ARKG, BBIO, ABOS, RXRX

Article By: Rod Raynovich

Monday, June 5, 2023 12:49 PM EDT

Biotech stocks remain sluggish but the longer-term outlook for breakthrough therapies - gene therapy, obesity, CNS, RNA - remain positive.

In this article: IWM, XBI, XLV Also: GERN, QDEL, PACB, SUPN, EVH, VCYT, ABOS

Article By: Rod Raynovich

Monday, May 22, 2023 12:09 PM EDT

Healthcare stocks have been lagging in 2023 with the XLV down 1.97% MTD and 3.34% YTD with CVS and UNH contributing to the weakness.

In this article: QQQ, XBI, XLV Also: CVS, REGN, IWM, CRSP, ABOS

Article By: Rod Raynovich

Monday, May 8, 2023 12:59 PM EDT

Biotech stocks were more constructive last week with some sharp moves up.

In this article: XBI, XLV Also: UNH, CYRX, QDEL, PACB, SUPN, CRSP, VCYT, ABOS